Shots:
Thierry spoke about the IND clearance of its lead candidate in hypoparathyroidism and the company’s clinical trial plans for rare endocrine and related diseases
Thierry also communicated about the closing of funding Series B equity financing round
The interview gives a deeper understanding of Hypoparathyroidism and its treatment options
Smriti: What did this Investigational…
